185 related articles for article (PubMed ID: 9516850)
1. Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation--sign of tumour cell revertance?
Ambros IM; Rumpler S; Luegmayr A; Hattinger CM; Strehl S; Kovar H; Gadner H; Ambros PF
Eur J Cancer; 1997 Oct; 33(12):2043-9. PubMed ID: 9516850
[TBL] [Abstract][Full Text] [Related]
2. In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei.
Valent A; Bénard J; Clausse B; Barrois M; Valteau-Couanet D; Terrier-Lacombe MJ; Spengler B; Bernheim A
Am J Pathol; 2001 May; 158(5):1579-84. PubMed ID: 11337354
[TBL] [Abstract][Full Text] [Related]
3. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
[TBL] [Abstract][Full Text] [Related]
4. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
5. Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyurea.
Narath R; Ambros IM; Kowalska A; Bozsaky E; Boukamp P; Ambros PF
Genes Chromosomes Cancer; 2007 Feb; 46(2):130-42. PubMed ID: 17106870
[TBL] [Abstract][Full Text] [Related]
6. MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells.
Corvi R; Amler LC; Savelyeva L; Gehring M; Schwab M
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5523-7. PubMed ID: 8202521
[TBL] [Abstract][Full Text] [Related]
7. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
Teitz T; Wei T; Liu D; Valentine V; Valentine M; Grenet J; Lahti JM; Kidd VJ
Oncogene; 2002 Mar; 21(12):1848-58. PubMed ID: 11896617
[TBL] [Abstract][Full Text] [Related]
8. Analysis of candidate gene co-amplification with MYCN in neuroblastoma.
George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson AD; Lunec J
Eur J Cancer; 1997 Oct; 33(12):2037-42. PubMed ID: 9516849
[TBL] [Abstract][Full Text] [Related]
9. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
10. Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.
Eggert A; Ho R; Ikegaki N; Liu XG; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):623-7. PubMed ID: 11107132
[TBL] [Abstract][Full Text] [Related]
11. Three neuroblastoma cell lines established from consecutive samples of one patient which show distinct morphologic features, MYCN amplification, and surface marker expression.
Kees UR; Ford J; Dawson VM; Ranford PR; Armstrong JA
Cancer Genet Cytogenet; 1992 Apr; 59(2):119-27. PubMed ID: 1581878
[TBL] [Abstract][Full Text] [Related]
12. Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridization.
McRobert TL; Rudduck C; Kees UR; Garson OM
Cancer Genet Cytogenet; 1992 Apr; 59(2):128-34. PubMed ID: 1581879
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line.
Corvi R; Savelyeva L; Amler L; Handgretinger R; Schwab M
Eur J Cancer; 1995; 31A(4):520-3. PubMed ID: 7576957
[TBL] [Abstract][Full Text] [Related]
14. Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid.
David K; Ehrhardt A; Ollert MW; Erttmann R; Bredehorst R; Vogel CW
Eur J Cancer; 1997 Oct; 33(12):1937-41. PubMed ID: 9516828
[TBL] [Abstract][Full Text] [Related]
15. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma.
Corvi R; Savelyeva L; Breit S; Wenzel A; Handgretinger R; Barak J; Oren M; Amler L; Schwab M
Oncogene; 1995 Mar; 10(6):1081-6. PubMed ID: 7700632
[TBL] [Abstract][Full Text] [Related]
16. Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification.
Chen B; Jhanwar SC; Ladanyi M
Diagn Mol Pathol; 2001 Jun; 10(2):100-4. PubMed ID: 11385318
[TBL] [Abstract][Full Text] [Related]
17. ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation.
Ren P; Yue M; Xiao D; Xiu R; Gan L; Liu H; Qing G
J Pathol; 2015 Jan; 235(1):90-100. PubMed ID: 25142020
[TBL] [Abstract][Full Text] [Related]
18. Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.
Prochazka P; Hrabeta J; Vícha A; Eckschlager T
Cancer Genet Cytogenet; 2010 Jan; 196(1):96-104. PubMed ID: 19963143
[TBL] [Abstract][Full Text] [Related]
19. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
[TBL] [Abstract][Full Text] [Related]
20. BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.
Hogarty MD; Liu X; Thompson PM; White PS; Sulman EP; Maris JM; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):559-62. PubMed ID: 11107117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]